Newborn affected by fetal inflammatory response syndrome
ICD-10 P02.70 is a billable code used to indicate a diagnosis of newborn affected by fetal inflammatory response syndrome.
Fetal inflammatory response syndrome (FIRS) is a condition that arises when the fetus experiences an inflammatory response due to maternal or placental infection, often linked to conditions such as chorioamnionitis. This syndrome can lead to significant neonatal complications, including respiratory distress, sepsis, and neurological impairment. The inflammatory response may be triggered by complications involving the placenta, umbilical cord, or membranes, such as placenta previa, cord prolapse, or chorioamnionitis. In cases of chorioamnionitis, the infection can ascend from the lower genital tract, leading to inflammation of the fetal membranes and potentially affecting the fetus's health. Newborns affected by FIRS may present with clinical signs such as fever, irritability, and feeding intolerance, necessitating close monitoring and intervention in a neonatal intensive care unit (NICU). Accurate coding of this condition is crucial for appropriate management and resource allocation in neonatal care.
Detailed clinical notes on the newborn's condition, including vital signs, laboratory results, and treatment plans.
Newborns presenting with respiratory distress and signs of infection in the NICU.
Ensure that all maternal complications are documented to support the diagnosis.
Comprehensive history of perinatal events and ongoing assessments of the newborn's health.
Follow-up visits for newborns with a history of FIRS and associated complications.
Consider the long-term implications of FIRS on pediatric development.
Used when a newborn with FIRS is evaluated in the NICU.
Document the newborn's clinical status, including any signs of infection or inflammatory response.
Neonatologists should ensure that all relevant clinical findings are recorded.
Key indicators include maternal history of infection, clinical signs of inflammation in the newborn, and laboratory findings that support the diagnosis of fetal inflammatory response syndrome.
